Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Puerta

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
International Journal of Molecular Sciences|January 11, 2025
Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic CohortRaquel Puerta, Amanda Cano, Pablo García-González, et al.
International Journal of Molecular Sciences|January 21, 2023
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive ImpairmentMarta Marquié, Fernando García-Gutiérrez, Adelina Orellana, et al.
Research Square|November 24, 2025
A peripheral proteomic signature of Alzheimer's disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL studyMaria Capdevila-Bayo, Rosanna Rossi, Itziar de Rojas, et al.
Frontiers in Artificial Intelligence|October 27, 2025
Federated learning for cognitive impairment detection using speech dataJosep Blazquez-Folch, María Limones Andrade, Berta Calm, et al.
Frontiers in Aging Neuroscience|May 20, 2026
Listening for Alzheimer's clues: machine learning analysis of multidomain speech features for cognitive impairment screeningJosep Blazquez-Folch, Berta Calm, Adrián Hinojosa-Calleja, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Alzheimer'S Research & Therapy|November 16, 2024
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohortLuis Castilla-Martí, Ainhoa García-Sánchez, Joan Martínez, et al.
Research Square|April 1, 2025
Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and Pathways for Alzheimer's DiseaseCarlos Cruchaga, Gyujin Heo, Alvin Thomas, et al.
Frontiers in Neuroscience|March 13, 2023
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohortMarta Marquié, Ainhoa García-Sánchez, Emilio Alarcón-Martín, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
International Journal of Molecular Sciences|January 11, 2025
Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic CohortRaquel Puerta, Amanda Cano, Pablo García-González, et al.
International Journal of Molecular Sciences|January 21, 2023
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive ImpairmentMarta Marquié, Fernando García-Gutiérrez, Adelina Orellana, et al.
Research Square|November 24, 2025
A peripheral proteomic signature of Alzheimer's disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL studyMaria Capdevila-Bayo, Rosanna Rossi, Itziar de Rojas, et al.
Frontiers in Artificial Intelligence|October 27, 2025
Federated learning for cognitive impairment detection using speech dataJosep Blazquez-Folch, María Limones Andrade, Berta Calm, et al.
Frontiers in Aging Neuroscience|May 20, 2026
Listening for Alzheimer's clues: machine learning analysis of multidomain speech features for cognitive impairment screeningJosep Blazquez-Folch, Berta Calm, Adrián Hinojosa-Calleja, et al.
Neuron|March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseasesMuhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Alzheimer'S Research & Therapy|November 16, 2024
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohortLuis Castilla-Martí, Ainhoa García-Sánchez, Joan Martínez, et al.
Research Square|April 1, 2025
Large-scale Plasma Proteomic Profiling Unveils Novel Diagnostic Biomarkers and Pathways for Alzheimer's DiseaseCarlos Cruchaga, Gyujin Heo, Alvin Thomas, et al.
Frontiers in Neuroscience|March 13, 2023
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohortMarta Marquié, Ainhoa García-Sánchez, Emilio Alarcón-Martín, et al.
Pageof 7